Vera Therapeutics (VERA) Interest & Investment Income (2020 - 2026)
Vera Therapeutics posted quarterly Interest & Investment Income of $6.4 million for Q1 2026, down 7.98% year-on-year from $6.9 million in Q1 2025, and up 15.19% on a QoQ basis from $5.5 million in Q4 2025.
Vera Therapeutics (VERA) has 7 years of Interest & Investment Income data on file, last reported at $6.4 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 7.98% year-over-year to $6.4 million; the trailing twelve-month figure through Mar 2026 stood at $23.9 million (up 2.11% YoY), and the FY2025 full-year result was $24.5 million, up 18.18% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $6.4 million, up from $5.5 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $6.9 million in Q1 2025 and bottomed at $26000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $4.2 million (2024), against an average of $3.6 million.
- The widest annual swing landed in 2022, when Interest & Investment Income surged 14800.0%; it then retreated 17.2% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $894000.0 in 2022, then soared by 119.24% to $2.0 million in 2023, then jumped by 239.95% to $6.7 million in 2024, then declined by 17.2% to $5.5 million in 2025, then grew by 15.19% to $6.4 million in 2026.
- The last three Interest & Investment Income figures came in at $6.4 million (Q1 2026), $5.5 million (Q4 2025), and $5.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Vera Therapeutics | 2.43 Bn | 1.83 Bn | - | 6.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.36 Mn |
| Dec 31, 2025 | 5.52 Mn |
| Sep 30, 2025 | 5.74 Mn |
| Jun 30, 2025 | 6.32 Mn |
| Mar 31, 2025 | 6.91 Mn |
| Dec 31, 2024 | 6.66 Mn |
| Sep 30, 2024 | 4.76 Mn |
| Jun 30, 2024 | 5.10 Mn |
| Mar 31, 2024 | 4.19 Mn |
| Dec 31, 2023 | 1.96 Mn |
| Sep 30, 2023 | 2.16 Mn |
| Jun 30, 2023 | 2.24 Mn |
| Mar 31, 2023 | 1.62 Mn |
| Dec 31, 2022 | 894,000.00 |
| Sep 30, 2022 | 567,000.00 |
| Jun 30, 2022 | 263,000.00 |
| Mar 31, 2022 | 26,000.00 |
| Dec 31, 2021 | 6,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 2,000.00 |
| Mar 31, 2020 | 6,000.00 |